Rafarma Pharmaceuticals just announced a cooperative research and development effort with Christian Albrecht University in Kiel on the following projects:
• The development of innovative Liposomal forms, anti-cancer and anti-tuberculosis drugs with certain targeted pharmacokinetic characteristics. The objective is to create parenteral medications based on non-dissolvable pharmaceutical substances using encapsulation and liposomes.
• The development of products with higher bioavailability (thereby increasing absorption rates) through modification of biopharmaceutical characteristics. The modifications are achieved by the creation of nano-crystals, which are formed through size reduction in the gas phase, as well as through synthetic crystallization.
These are only the first of several projects Rafarma is exploring in cooperation with Christian Albrecht University.
Rafarma CEO Dave Anderson stated, "This cooperative effort creates a synergy between a top-level research university and a state-of-the-art pharmaceutical production plant, which will open up many opportunities now and in the future for both Rafarma and Christian Albrecht University."
Newly-appointed board member and CAU faculty member, Dr. Hartwig Steckel [the Director of the Department of Pharmaceutics and Biopharmaceutics (Institute of Pharmacy) at Christian Albrecht University], commented, "This relationship is extremely exciting and I look forward to progressing rapidly with RAFARMA-CAU joint developments."
The University of Kiel, also known as Christian Albrecht University (CAU), was formally inaugurated in 1665. During its almost 350-year existence, the Christian-Albrechts-Universität in Kiel has given impetus and set new standards in many fields, including Pharmaceutical Technology. That much is clear from its roll-call of Nobel Prize winners. Some of the many recipients of this award to have taught at Kiel were Philipp Lenard (Physics 1905), Max Planck (Physics 1918) and Otto Diels (Chemistry 1950). Over the course of its history, the CAU has developed from a regional training academy to an internationally recognized university.
For more information on Rafarma, visit Rafarma.com
Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.